Shopping Cart 0
Cart Subtotal
AED 0

Allergan Plc (AGN)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Allergan Plc (AGN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology, women's health, urology and anti-infective therapeutic categories. The company sells its products primarily to retailers, drug wholesalers and distributors, including national retail drug and food store chains, mail order retailers, hospitals, clinics, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has operations in several countries across the world including the US, Canada, China, India, and other high growth markets in Europe, Southeast Asia, Middle East and Latin America. Allergan is headquartered in Dublin, Ireland.

Allergan Plc Key Recent Developments

Mar 03, 2017: Allergan Presents Data From 21 Abstracts At The 2017 American Academy Of Dermatology Meeting In Orlando, FL

Feb 27, 2017: Lisa DeFrancesco, Vice President of Investor Relations, to Leave Allergan

Feb 08, 2017: Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016

Jan 23, 2017: Allergan Continues Commitment to Future of Headache Medicine with Educational Grants for Young Neurologists and Research Scientists

Jan 05, 2017: Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Allergan Plc-Key Facts 6

Allergan Plc-Key Employees 7

Allergan Plc-Key Employee Biographies 8

Allergan Plc-Major Products and Services 10

Allergan Plc-Pharmaceutical Pipeline Products Data 12

Allergan Plc, Pipeline Products by Therapy Area 12

Allergan Plc, Pipeline Products by Development Phase 13

Allergan Plc-History 14

Allergan Plc-Company Statement 27

Allergan Plc-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Section 2-Company Analysis 37

Allergan Plc-Business Description 37

Allergan Plc-Corporate Strategy 38

Allergan Plc-SWOT Analysis 39

SWOT Analysis-Overview 39

Allergan Plc-Strengths 39

Allergan Plc-Weaknesses 40

Allergan Plc-Opportunities 41

Allergan Plc-Threats 43

Allergan Plc-Key Competitors 44

Section 3-Company Financial Ratios 45

Financial Ratios-Capital Market Ratios 45

Financial Ratios-Annual Ratios 46

Performance Chart 48

Financial Performance 48

Financial Ratios-Interim Ratios 49

Financial Ratios-Ratio Charts 50

Section 4-Company's Lifesciences Financial Deals and Alliances 51

Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 51

Allergan Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 52

Allergan Plc, Recent Deals Summary 53

Section 5-Company's Recent Developments 54

Mar 03, 2017: Allergan Presents Data From 21 Abstracts At The 2017 American Academy Of Dermatology Meeting In Orlando, FL 54

Feb 27, 2017: Lisa DeFrancesco, Vice President of Investor Relations, to Leave Allergan 56

Feb 08, 2017: Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016 57

Jan 23, 2017: Allergan Continues Commitment to Future of Headache Medicine with Educational Grants for Young Neurologists and Research Scientists 61

Jan 05, 2017: Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook 62

Nov 14, 2016: Adriane M. Brown to Join Allergan Board of Directors 63

Nov 02, 2016: Allergan Reports Third Quarter 2016 Continuing Operations Performance with GAAP Net Revenues of $3.6 Billion; Announces Accelerated Share Repurchase, Initiation of Cash Dividend 64

Oct 29, 2016: Data Presented at IDWeek Highlight Risk Factors for Carbapenem Resistance Among Patients Hospitalized for Serious Infections 68

Oct 26, 2016: Allergan Announces Changes to Board Leadership 69

Oct 16, 2016: Allergan Demonstrates Ongoing Commitment to Irritable Bowel Syndrome (IBS) with Development of IBS CounSEL 70

Section 6-Appendix 71

Methodology 71

Ratio Definitions 71

About GlobalData 75

Contact Us 75

Disclaimer 75


List Of Figure

List of Figures

Allergan Plc, Pipeline Products by Therapy Area 12

Allergan Plc, Pipeline Products by Development Phase 13

Allergan Plc, Performance Chart (2012-2016) 48

Allergan Plc, Ratio Charts 50

Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 51

Allergan Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 52


List Of Table

List of Tables

Allergan Plc, Key Facts 6

Allergan Plc, Key Employees 7

Allergan Plc, Key Employee Biographies 8

Allergan Plc, Major Products and Services 10

Allergan Plc, Number of Pipeline Products by Therapy Area 12

Allergan Plc, Number of Pipeline Products by Development Stage 13

Allergan Plc, History 14

Allergan Plc, Other Locations 28

Allergan Plc, Subsidiaries 28

Allergan Plc, Key Competitors 44

Allergan Plc, Ratios based on current share price 45

Allergan Plc, Annual Ratios 46

Allergan Plc (Cont...1), Annual Ratios 47

Allergan Plc, Interim Ratios 49

Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 51

Allergan Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 52

Allergan Plc, Recent Deals Summary 53

Currency Codes 71

Capital Market Ratios 71

Equity Ratios 72

Profitability Ratios 72

Cost Ratios 73

Liquidity Ratios 73

Leverage Ratios 73

Efficiency Ratios 74

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Allergan Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Teva Pharmaceutical Industries Ltd, Pfizer Inc, Mylan NV, Merrion Pharmaceuticals Plc, Mallinckrodt Plc, Cardinal Health Inc, AmerisourceBergen Corp, AMAG Pharmaceuticals Inc